Search Results for Bristol CEO \'Out Hunting\' for Deal With $10 Billion in Cash - Bloomberg:

Free Executive Magazines and eBooks

BRISTOL MYERS SQUIBB CO ($BMY) CEO James M. Cornelius Retiring

On March 2, 2010, Bristol-Myers Squibb Company (the "Company"), announced the retirement of James M. Cornelius as Chief Executive Officer, effective May 4, 2010. He will remain Chairman of the Board of Directors. On March 2, 2010,

An $11 Billion Challenge for Bristol-Myers' New CEO

GM CEO: Bankruptcy an option, but not inevitableBizjournals.com, NCGM's stock was trading up 7 percent to $2.25 in mid-day trading on Wall Street on Monday. GM has accepted more than $13 billion in federal bailout funds in the past year

What New Bristol-Myers CEO Can Expect: More Management Churn and

The ascent of Lamberto Andreotti to CEO of Bristol-Myers Squibb (BMY) sets the stage for two events: Potential continued churn in BMS leadership and a.

Bristol-Myers Appoints New CEO | TopNews United States

Bristol-Myers Squibb Co. announced late Tuesday that company veteran Lamberto Andreotti, the drug maker's President and Chief Operating Officer, will become Chief Executive on May 4, a step that should continue the company's

Bristol-Myers Names Andreotti CEO to Replace Cornelius Upon May

Andreotti, 59, will replace James Cornelius , 66, the CEO since 2007, when Cornelius retires May 4, Bristol-Myers said yesterday in a statement. Andreotti will meet with investors tomorrow in New York, where he said he will lay out his

Bristol-Myers Squibb to Replace CEO | Top Industry News

The pharmaceutical giant said its President and Chief Operating Officer, Lamberto Andreotti, 59, who also sits on the company'sboard of directors, will replace the Cornelius in the position."I have a high level of confidence in Lamberto

Bristol-Myers' Cornelius to retire as CEO, but still head board

Cornelius had been brought in after Bristol's board fired CEO Peter R. Dolan in September 2006 at the insistence of a federal monitor who was overseeing its compliance with standards imposed to settle federal charges in a big accounting

Healthcare Sales & Marketing Network - HSMN NewsFeed: Bristol

Bristol-Myers Squibb Names Lamberto Andreotti CEO, Effective May 4; James Cornelius to Retire as CEO, Remain as Chairman (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)

Bristol-Myers Squibb Names Lamberto Andreotti CEO, Effective May 4

Mar 2, 2010 - Bristol-Myers Squibb Company (NYSE BMY) today announced that Lamberto Andreotti, 59, has been designated by the Board of Directors to serve as the.

Bristol-Myers names Lamberto Andreotti next CEO - MarketWatch

SAN FRANCISCO (MarketWatch) -- Bristol-Myers Squibb Co. said late Tuesday that Lamberto Andreotti will become the drugmaker's new chief executive May 4. Andreotti, 59, was named president and chief operating officer in March 2009.

Free Business and Tech Magazines and eBooks
Search Form: